Announcement
14 Jun 2021
India has imposed an export licensing requirement on the injection and the Active Pharmaceutical Ingredient (API) of the drug Remdesivir.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
14 Jun 2021
Revocation date:
23 Feb 2022
Updated: 14 Jun 2021
Export licensing requirement
On 14 June 2021, the Indian Directorate General of Foreign Trade through Notification No. 08/2015-2020 amended the export policy of Remdesivir injections and Remdesivir Active Pharmaceutical Ingred...
Sign in to see more
Related State Acts
Threads
See all
This state act is not part of any Thread yet.